Donovan Joanne M. - Sep 20, 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: CMO
Signature: John R. Moore Attorney-in-Fact for Donovan Joanne M.
Stock symbol: EWTX
Transactions as of: Sep 20, 2024
Transactions value $: -$202,603
Form type: 4
Date filed: 9/24/2024, 08:24 PM
Previous filing: Aug 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Sale	-$203K	-7.16K	-33%	$28.29	14.5K	Sep 20, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $28.28 to $28.29, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	Includes 1,803 shares purchased on May 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.

Content

The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $28.28 to $28.29, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes 1,803 shares purchased on May 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.